Aquarius Surgical Technologies Inc
Aquarius Surgical Technologies Inc., through its subsidiary, Surgical Lasers Inc., engages in the development, sale, distribution, and marketing of technologies for use in surgical and other environments in Canada and the United States. It offers integrated laser-based solutions across multiple medical disciplines, including urology, gynecology, ophthalmology, thoracic, ENT, cardiovascular, and n… Read more
Aquarius Surgical Technologies Inc (AQQRF) - Net Assets
Latest net assets as of September 2025: $-5.87 Million USD
Based on the latest financial reports, Aquarius Surgical Technologies Inc (AQQRF) has net assets worth $-5.87 Million USD as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($2.22 Million) and total liabilities ($8.09 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-5.87 Million |
| % of Total Assets | -263.92% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 177.57 |
Aquarius Surgical Technologies Inc - Net Assets Trend (1997–2025)
This chart illustrates how Aquarius Surgical Technologies Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Aquarius Surgical Technologies Inc (1997–2025)
The table below shows the annual net assets of Aquarius Surgical Technologies Inc from 1997 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-03-31 | $-5.77 Million | -25.34% |
| 2024-03-31 | $-4.61 Million | -19.69% |
| 2023-03-31 | $-3.85 Million | -19.69% |
| 2022-03-31 | $-3.21 Million | -34.25% |
| 2021-03-31 | $-2.39 Million | -247.48% |
| 2020-03-31 | $-689.15K | -51.83% |
| 2019-03-31 | $-453.89K | -452.71% |
| 2018-03-31 | $128.69K | -97.57% |
| 2017-03-31 | $5.30 Million | +237.19% |
| 2016-03-31 | $-3.86 Million | +1.28% |
| 2015-03-31 | $-3.91 Million | -6.58% |
| 2014-03-31 | $-3.67 Million | +4.76% |
| 2013-03-31 | $-3.86 Million | -8.09% |
| 2012-03-31 | $-3.57 Million | -4.81% |
| 2011-03-31 | $-3.40 Million | -7.74% |
| 2010-03-31 | $-3.16 Million | -13.55% |
| 2009-03-31 | $-2.78 Million | -17.04% |
| 2008-03-31 | $-2.38 Million | -16.47% |
| 2007-03-31 | $-2.04 Million | -4.97% |
| 2006-03-31 | $-1.94 Million | +39.86% |
| 2005-03-31 | $-3.23 Million | -11.99% |
| 2004-03-31 | $-2.89 Million | -10.46% |
| 2003-03-31 | $-2.61 Million | -9.12% |
| 2002-03-31 | $-2.40 Million | +67.14% |
| 2001-03-31 | $-7.29 Million | -19.51% |
| 2000-03-31 | $-6.10 Million | -29.79% |
| 1999-03-31 | $-4.70 Million | -34.29% |
| 1998-03-31 | $-3.50 Million | -218.18% |
| 1997-03-31 | $-1.10 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Aquarius Surgical Technologies Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 2624197000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (March 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $19.95 Million | % |
| Other Components | $9.32 Million | % |
| Total Equity | $-5.77 Million | 100.00% |
Aquarius Surgical Technologies Inc Competitors by Market Cap
The table below lists competitors of Aquarius Surgical Technologies Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Sentia Asa
OL:SNTIA
|
$56.33K |
|
US Stem Cell Inc
PINK:USRM
|
$56.37K |
|
Gloo Holdings, Inc. Class A Common Stock
NASDAQ:GLOO
|
$56.38K |
|
Namkwang Engineering & Construction Co. Ltd.
KQ:001260
|
$56.47K |
|
Kwang Dong Pharmaceutical Co. Ltd.
KQ:009290
|
$56.25K |
|
RDOR3F
SA:RDOR3F
|
$56.25K |
|
PHARMEDIC JSC
VN:PMC
|
$56.24K |
|
Invesco MSCI Europe ESG Climate Paris Aligned UCITS EUR Acc
XETRA:PAUE
|
$56.19K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Aquarius Surgical Technologies Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from -4,605,556 to -5,772,804, a change of -1,167,248.
- Net loss of 1,167,248 reduced equity.
- Other factors decreased equity by 0.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-1.17 Million | -20.22% |
| Total Change | $- | % |
Book Value vs Market Value Analysis
This analysis compares Aquarius Surgical Technologies Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 1997-03-31 | $-0.98 | $0.00 | x |
| 1998-03-31 | $-1.75 | $0.00 | x |
| 1999-03-31 | $-2.56 | $0.00 | x |
| 2000-03-31 | $-2.61 | $0.00 | x |
| 2001-03-31 | $-3.45 | $0.00 | x |
| 2002-03-31 | $-0.89 | $0.00 | x |
| 2003-03-31 | $-0.79 | $0.00 | x |
| 2004-03-31 | $-0.88 | $0.00 | x |
| 2005-03-31 | $-0.98 | $0.00 | x |
| 2006-03-31 | $-0.37 | $0.00 | x |
| 2007-03-31 | $-0.38 | $0.00 | x |
| 2008-03-31 | $-0.44 | $0.00 | x |
| 2009-03-31 | $-0.52 | $0.00 | x |
| 2010-03-31 | $-0.59 | $0.00 | x |
| 2011-03-31 | $-0.63 | $0.00 | x |
| 2012-03-31 | $-0.66 | $0.00 | x |
| 2013-03-31 | $-0.71 | $0.00 | x |
| 2014-03-31 | $-0.68 | $0.00 | x |
| 2015-03-31 | $-0.73 | $0.00 | x |
| 2016-03-31 | $-0.72 | $0.00 | x |
| 2017-03-31 | $0.85 | $0.00 | x |
| 2018-03-31 | $0.01 | $0.00 | x |
| 2019-03-31 | $-0.02 | $0.00 | x |
| 2020-03-31 | $-0.03 | $0.00 | x |
| 2021-03-31 | $-0.10 | $0.00 | x |
| 2022-03-31 | $-0.14 | $0.00 | x |
| 2023-03-31 | $-0.15 | $0.00 | x |
| 2024-03-31 | $-0.17 | $0.00 | x |
| 2025-03-31 | $-0.21 | $0.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Aquarius Surgical Technologies Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -1279.85%
- • Asset Turnover: 0.05x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-168.13%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 1997 | 0.00% | -100.00% | 1.00x | 0.00x | $-1.69 Million |
| 1998 | 0.00% | -54.55% | 2.10x | 0.00x | $-2.05 Million |
| 1999 | 0.00% | -35.48% | 1.94x | 0.00x | $-630.00K |
| 2000 | 0.00% | -100.00% | 1.27x | 0.00x | $-790.00K |
| 2001 | 0.00% | -264.61% | 0.67x | 0.00x | $-491.78K |
| 2002 | 0.00% | -186.82% | 0.95x | 0.00x | $-553.82K |
| 2003 | 0.00% | -90.37% | 1.46x | 0.00x | $42.98K |
| 2004 | 0.00% | -247.57% | 2.00x | 0.00x | $-484.74K |
| 2005 | 0.00% | -134.45% | 1.95x | 0.00x | $-22.93K |
| 2006 | 0.00% | -123.36% | 1.60x | 0.00x | $-116.69K |
| 2007 | 0.00% | -34.17% | 1.92x | 0.00x | $107.51K |
| 2008 | 0.00% | -130.13% | 1.64x | 0.00x | $-98.49K |
| 2009 | 0.00% | -188.83% | 1.19x | 0.00x | $-126.94K |
| 2010 | 0.00% | -159.58% | 1.29x | 0.00x | $-61.06K |
| 2011 | 0.00% | -80.85% | 1.78x | 0.00x | $95.96K |
| 2012 | 0.00% | -99.38% | 1.17x | 0.00x | $81.00K |
| 2013 | 0.00% | -156.18% | 0.74x | 0.00x | $96.78K |
| 2014 | 0.00% | 89.23% | 0.98x | 0.00x | $550.98K |
| 2015 | 0.00% | 0.00% | 0.00x | 0.00x | $149.93K |
| 2016 | 0.00% | 0.00% | 0.00x | 0.00x | $548.91K |
| 2017 | -17.46% | -14865.28% | 0.00x | 1.67x | $-1.38 Million |
| 2018 | -4858.18% | -641.52% | 0.60x | 12.53x | $-6.26 Million |
| 2019 | 0.00% | -403.35% | 0.23x | 0.00x | $-1.54 Million |
| 2020 | 0.00% | -168.00% | 0.58x | 0.00x | $-1.54 Million |
| 2021 | 0.00% | -310.30% | 0.62x | 0.00x | $-1.57 Million |
| 2022 | 0.00% | -262.22% | 0.37x | 0.00x | $-537.71K |
| 2023 | 0.00% | -355.09% | 0.30x | 0.00x | $-338.65K |
| 2024 | 0.00% | -369.14% | 0.36x | 0.00x | $-297.10K |
| 2025 | 0.00% | -1279.85% | 0.05x | 0.00x | $-589.97K |
Industry Comparison
This section compares Aquarius Surgical Technologies Inc's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $694,749,556
- Average return on equity (ROE) among peers: -25.46%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Aquarius Surgical Technologies Inc (AQQRF) | $-5.87 Million | 0.00% | N/A | $56.33K |
| Advanced Biomedical Technologies Inc (ABMT) | $-4.46 Million | 0.00% | 0.00x | $14.18K |
| Abbott Laboratories (ABT) | $4.82 Billion | 39.04% | 1.31x | $191.37 Billion |
| Acarix AB (publ) (ACIXF) | $1.93 Million | -127.02% | 0.21x | $26.42 Million |
| Adagio Medical Holdings, Inc Common Stock (ADGM) | $-72.62 Million | 0.00% | 0.00x | $4.05 Million |
| Adm Tronics Unltd (ADMT) | $-12.69K | 0.00% | 0.00x | $3.17 Million |
| Aethlon Medical Inc (AEMD) | $-3.07 Million | 0.00% | 0.00x | $2.79 Million |
| Acutus Medical Inc (AFIB) | $126.58 Million | -80.56% | 0.52x | $732.88K |
| Adapthealth Corp (AHCO) | $2.07 Billion | 7.56% | 1.54x | $914.25 Million |
| Allied Healthcare Products Inc. (AHPIQ) | $8.88 Million | -33.95% | 1.22x | $726.24 |
| 20/20 Biolabs, Inc. Common Stock (AIDX) | $3.39 Million | -59.65% | 0.38x | $9.18 Million |